Loading...
•
Sep 30, 2024
Surgery Partners Q3 2024 Earnings Report
Reported strong growth in Adjusted EBITDA and revenue, driven by core organic growth and inorganic growth strategies.
Key Takeaways
Surgery Partners reported a 14.3% increase in revenue to $770.4 million for the third quarter of 2024. Adjusted EBITDA was $128.6 million, representing a 21.9% increase compared to the prior year period. The company reaffirmed its full-year 2024 revenue and Adjusted EBITDA guidance.
Revenues increased by 14.3% to $770.4 million compared to the prior year period.
Same-facility revenues increased by 4.2%.
Adjusted EBITDA was $128.6 million, a 21.9% increase year-over-year.
Adjusted EBITDA margin expanded by 100 basis points to 16.7%.
Forward Guidance
The Company reaffirmed its outlook for 2024 revenues and Adjusted EBITDA to be greater than $3.075 billion and greater than $508 million, respectively.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...